Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. (Record no. 24441644)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02435 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517005500.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201503s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1527-7755 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.2013.54.3298 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Cainap, Calin |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150316 |
245 00 - TITLE STATEMENT | |
Title | Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | Jan 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 172-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Hepatocellular |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hand-Foot Syndrome |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypertension |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Niacinamide |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Odds Ratio |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenylurea Compounds |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor Protein-Tyrosine Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sorafenib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qin, Shukui |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Wen-Tsung |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chung, Ik Joo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pan, Hongming |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cheng, Ying |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kudo, Masatoshi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kang, Yoon-Koo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Pei-Jer |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Toh, Han-Chong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gorbunova, Vera |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eskens, Ferry A L M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qian, Jiang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McKee, Mark D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ricker, Justin L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carlson, Dawn M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | El-Nowiem, Saied |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 33 |
-- | no. 2 |
-- | p. 172-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2013.54.3298">https://doi.org/10.1200/JCO.2013.54.3298</a> |
Public note | Available from publisher's website |
No items available.